Month: October 2016
-
Institutes, Companies Form Business to Bridge Discovery Gap
Three research institutions with pharmaceutical and venture capital companies are creating a new enterprise to fill the drug development gap between proof-of-concept and initial clinical trials.
-
Foundation Medicine, Sarah Cannon Partner on Cancer Trials
Foundation Medicine, a cancer diagnostics company, and Sarah Cannon Research Institute plan to apply genomic testing of patients’ tumors in clinical trials of personalized treatments.
-
Biotech, Univ of Miami Spin-Off Vaccine Company
Biotechnology company Heat Biologics Inc. is licensing research from University of Miami in Florida to develop vaccines against infectious diseases, starting with the Zika virus, in a new subsidiary.
-
Preventive Drugs Offer No Benefit for Children’s Migraine
A clinical trial testing drugs for depression and seizures, but sometimes prescribed to prevent migraines, shows the drugs to be no better than a placebo in preventing migraines among children.
-
Organ Chip System Designed to Simulate Smoking Effects
A system that combines human airway tissue on a chip with components that simulate cigarette smoking is being developed to test treatments for lung disorders.
-
Skin Patch Shown to Increase Peanut Tolerance in Children
A skin patch worn by children with peanut allergies was shown in a clinical trial to increase the wearers’ tolerance for peanuts by 10 times after 1 year.
-
Engineered Mosquito Production Facility Opens
A new industrial lab to produce mosquitoes genetically engineered to prevent the spread of infectious diseases opened in Piracicaba, Brazil.
-
Trial to Test Drug Combination for Hospital Infections
A clinical trial scheduled for early 2017 plans to assess the activity of two drugs to treat antibiotic-resistant infections often found in health care facilities.
-
ALS Soy Peptide Trial Completes Enrollment
A clinical trial testing a peptide found in soy as a potential treatment for amyotrophic lateral sclerosis or ALS completed its enrollment of 50 participants.
-
Google Acquires Visual Interaction Tech Company
Google is acquiring Eyefluence Inc., developer of a technology that allows individuals to interact with computers, phones, and other devices using only their eyes.